
1. BMC Infect Dis. 2021 Oct 18;21(1):1072. doi: 10.1186/s12879-021-06765-6.

A case of coinfection of a pediatric patient with acute SARS-COV-2 with MIS-C and
severe DENV-2 in Mexico: a case report.

Jose PM(1)(2), Paola ZS(1), Eduardo DG(2), Arturo SMO(3), Fernando BG(4).

Author information: 
(1)Laboratorio de Medicina Traslacional, Escuela Superior de Medicina, Instituto 
Politecnico Nacional, Salvador Díaz Mirón esq. Plan de San Luis S/N, Miguel
Hidalgo, Casco de Santo Tomas, 11340, Mexico, CDMX, Mexico.
(2)Laboratorio de Biología Molecular, Laboratorio Estatal de Salud Pública del
Estado de México, Tollocan S/N Colonia Moderna de la Cruz, 50180, Toluca,,
Mexico.
(3)Departamento de Epidemiología del Instituto de Seguridad Social del Estado de 
México y Municipios, ISSEMyM, Av. Hidalgo Pte. No. 600, Col. La Merced, 50080,
Toluca, Estado de México, Mexico.
(4)Laboratorio de Biología Molecular, Laboratorio Estatal de Salud Pública del
Estado de México, Tollocan S/N Colonia Moderna de la Cruz, 50180, Toluca,,
Mexico. mijomeil@hotmail.com.

BACKGROUND: COVID-19 cases have been increasing since the epidemic started. One
of the major concerns is how clinical symptomatology would behave after
coinfection with another virus.
CASE PRESENTATION: In this case report, a pediatric native patient from Estado de
Mexico (EDOMEX), MEX had severe DENV-2 and acute SARS-CoV-2 at the same time. The
clinical features were severe thrombocytopenia, secondary septic shock, cerebral 
edema, pericardial effusion, fluid overload that exhibited bipalpebral edema in
all four extremities, hemophagocytic lymphohistiocytosis (HLH), coronary artery
ectasia (CAE), multisystemic inflammatory syndrome in children (MIS-C), and
probable COVID-19 pneumonia or acute respiratory distress syndrome (ARDS) that
triggered patient intubation. The patient presented unusual symptomatology
according to the literature. After 15 days of intubation and 15 more days under
surveillance, he was released without respiratory sequelae and without treatment 
after major clinical improvement.
CONCLUSION: The aim of this manuscript is to present clinical challenges that
coinfection may cause in pediatric patients, even though COVID-19 in children
does not tend to be as severe as in other sectors of the population.

© 2021. The Author(s).

DOI: 10.1186/s12879-021-06765-6 
PMCID: PMC8521498
PMID: 34663252  [Indexed for MEDLINE]

